Monday, 12. October 2026 Β· Next update: 10:00 DE EN Log in
Cassandra.news
Tomorrow's news. Today.
πŸ“ˆ Economy Β· Next Month

US Federal Reserve holds the federal funds rate unchanged at 3.75%-4.00% at the October 28, 2026 FOMC meeting (confirmed by Fed press release or Bloomberg by October 28, 2026, 2:00 PM ET)

Pending ✦ AI-generated prediction Published on 12. October 2026 · Predicted for 28. October 2026 · Based on: Historical Cycle
Probability
83%

The US Federal Reserve last raised rates on September 16, 2026 by 25 basis points to 3.75%-4.00%. CME FedWatch data (rateprobability.com, October 12, 2026) shows only ~16-18% probability of another hike at the October 28 meeting; ~82-84% for an unchanged hold. Weak September payrolls and mixed inflation data have shifted the consensus timing for the next hike to the December 9, 2026 meeting, where markets price ~76% probability of a move. No specific Polymarket market found for the October meeting; anchor: CME FedWatch ~84% Hold.

Data basis for this prediction
  • rateprobability.com / CME FedWatch: ~16–18 % Hike-Wahrscheinlichkeit Oktober-FOMC 2026 (Stand 12.10.2026)
  • Forbes: Fed erhΓΆht Leitzins am 16.09.2026 auf 3,75 %–4,00 % β€” nΓ€chste Sitzung 27.–28. Oktober
  • fedratecalc.com: FOMC-Kalender 2026 β€” verbleibende Sitzungen 27.–28. Oktober, 8.–9. Dezember

Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.

Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
Related Predictions
πŸ“ˆ Economy ✦ AI

Citigroup (NYSE: C) beats Q3-FY2026 EPS consensus estimate of $2.65 β€” Earnings report October 13, 2026, pre-market open (confirmed by Citi Investor Relations or Bloomberg by October 13, 2026)

Citigroup reports Q3-FY2026 results on October 13, 2026, pre-market open. General consensus: ~$2.65 EPS (Pluang/market majority), Alphastreet estimate: $2.62. Benzinga anticipates higher year-over-year earnings. The 90-day estimate stood at $2.69 β€” the modest downward drift suggests conservative analyst positioning, which increases the probability of a positive surprise. Large US banks historically beat EPS consensus in ~65% of quarters. The $2.65 threshold corresponds to the upper end of the consensus range.

60%
Tomorrow Β· Predicted for 13. Oct 2026
πŸ“ˆ Economy ✦ AI

Nikkei 225 (Tokyo Stock Exchange) closes above 71,000 points on December 31, 2026 (confirmed by TSE closing price or Bloomberg by January 1, 2027)

The Nikkei 225 is trading at ~69,170 points on October 12, 2026 (+43.5% YoY, 52-week high: 72,832). A threshold of 71,000 requires a further gain of ~+2.6% over the remaining ~11 weeks of the year. Analyst consensus (QUICK survey, 114 firms): year-end median 71,704 points; Nomura base case 70,000; BofA (most bearish outlier) 61,000. Drivers: 19.2% TOPIX earnings growth forecast for FY2026 (Nomura), structural capital inflows into Japanese equities (Buffett effect), BoJ terminal rate expectation ~1.1% β€” anchored, no shock expected. The 71,000 threshold sits just below the analyst consensus median and is therefore rated as achievable by slightly more than half of polled houses.

62%
Next Year Β· Predicted for 31. Dec 2026
πŸ“ˆ Economy ✦ AI

Johnson & Johnson (NYSE: JNJ) beats Q3-FY2026-EPS consensus estimate of $2.66 β€” earnings report October 13, 2026 before market open (confirmed by JNJ Investor Relations or Bloomberg by October 13, 2026)

Johnson & Johnson reports Q3-FY2026 earnings on October 13, 2026 before market open. Analyst consensus EPS stands at $2.66 (MarketBeat, October 12, 2026). J&J has beaten consensus EPS estimates in approximately 75-80% of recent quarters. The Innovative Medicine segment (oncology, immunology) and stable MedTech demand support another beat. No specific Polymarket or Metaculus market found; probability conservatively derived from historical beat rate.

68%
Tomorrow Β· Predicted for 13. Oct 2026